Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Strategies to overcome DC dysregulation in the tumor microenvironment. | Front Immunol | 2022 | 36275666 | PubTator, text mining | PubMed |
| Novel IRAK Degraders for Treating Cancer. | ACS Med Chem Lett | 2022 | 36267130 | PubTator, text mining | PubMed |
| Comparative and evolutionary analysis of RIP kinases in immune responses. | Front Genet | 2022 | 36263437 | PubTator, text mining | PubMed |
| Roles and mechanisms of garlic and its extracts on atherosclerosis: A review. | Front Pharmacol | 2022 | 36263122 | PubTator, text mining | PubMed |
| A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening. | Front Genet | 2022 | 36246599 | PubTator, text mining | PubMed |
| The lung in inborn errors of immunity: From clinical disease patterns to molecular pathogenesis. | J Allergy Clin Immunol | 2022 | 36244852 | PubTator, text mining | PubMed |
| SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling. | Front Immunol | 2022 | 36238311 | PubTator, text mining | PubMed |
| Discovery of E3 Ligase Ligands for Target Protein Degradation. | Molecules | 2022 | 36235052 | PubTator, text mining | PubMed |
| Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies. | Molecules | 2022 | 36234844 | PubTator, text mining | PubMed |
| Mechanisms of Foreign Body Response Mitigation by Nitric Oxide Release. | Int J Mol Sci | 2022 | 36232937 | PubTator, text mining | PubMed |
| Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies. | Int J Mol Sci | 2022 | 36232447 | PubTator, text mining | PubMed |
| The Railmap of Type I Interferon Induction: Subcellular Network Plan and How Viruses Can Change Tracks. | Cells | 2022 | 36231111 | PubTator, text mining | PubMed |
| Updates on the Management of Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 36230677 | PubTator, text mining | PubMed |
| Interleukin-1 receptor associated kinase 1 (IRAK1) is epigenetically activated in luminal epithelial cells in prostate cancer. | Front Oncol | 2022 | 36226067 | PubTator, text mining | PubMed |
| Epigenetic regulation of B cells and its role in autoimmune pathogenesis. | Cell Mol Immunol | 2022 | 36220996 | PubTator, text mining | PubMed |
| NIPK, a protein pseudokinase that interacts with the C subunit of the transcription factor NF-Y, is involved in rhizobial infection and nodule organogenesis. | Front Plant Sci | 2022 | 36212340 | PubTator, text mining | PubMed |
| Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience. | Front Immunol | 2022 | 36211396 | PubTator, text mining | PubMed |
| The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification. | Front Immunol | 2022 | 36211357 | PubTator, text mining | PubMed |
| Betulin, an Anti-Inflammatory Triterpenoid Compound, Regulates MUC5AC Mucin Gene Expression through NF-kB Signaling in Human Airway Epithelial Cells. | Biomol Ther (Seoul) | 2022 | 36203319 | PubTator, text mining | PubMed |
| Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments. | Front Pharmacol | 2022 | 36188605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=34